HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
N- (N- gamma- L- glutamyl- 2- amino- 2- (4- (4- S- nitrosomercapto- 1- methylpiperidine)acetyl)glycine)
thrombosis inhibitor
Also Known As:
LA 810; LA-810; LA810; LA810 cpd
Networked:
1
relevant articles (
1
outcomes,
0
trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Amino Acids, Peptides, and Proteins: 1
Amino Acids: 30675
Glycine: 5151
N-(N-gamma-L-glutamyl-2-amino-2-(4-(4-S-nitrosomercapto-1-methylpiperidine)acetyl)glycine): 1
Organic Chemicals: 133
Nitroso Compounds: 446
N-(N-gamma-L-glutamyl-2-amino-2-(4-(4-S-nitrosomercapto-1-methylpiperidine)acetyl)glycine): 1
Sulfur Compounds: 278
Sulfhydryl Compounds: 4168
N-(N-gamma-L-glutamyl-2-amino-2-(4-(4-S-nitrosomercapto-1-methylpiperidine)acetyl)glycine): 1
Experts
1.
Badimon, Lina
: 1 article (03/2004)
2.
Baldellou, María Isabel
: 1 article (03/2004)
3.
Salas, Eduardo
: 1 article (03/2004)
4.
Segalés, Estefania
: 1 article (03/2004)
5.
Vilahur, Gemma
: 1 article (03/2004)
Related Diseases
1.
Thrombosis (Thrombus)
03/01/2004 - "
LA810 significantly decreased thrombus formation at any degree of vascular damage and shear rate (p<0.001) without hypotensive side-effects or heart rate variations.
"
03/01/2004 - "
This new anti-ischemic NO-donor (NOd) LA810 that inhibits platelet function without hypotensive side-effects seems a highly efficacious strategy to reduce acute thrombosis triggered by coronary artery disease.
"
03/01/2004 - "
We have studied whether donation of NO with a novel platelet-selective S-nitrosothiol compound (LA810) at a systemic level can inhibit thrombosis elicited by damaged vessel wall (eroded and disrupted vessel wall) at hemodynamic conditions typical of patent and stenotic coronary arteries.
"
2.
Coronary Artery Disease (Coronary Atherosclerosis)
03/01/2004 - "
This new anti-ischemic NO-donor (NOd) LA810 that inhibits platelet function without hypotensive side-effects seems a highly efficacious strategy to reduce acute thrombosis triggered by coronary artery disease.
"
Related Drugs and Biologics
1.
S-Nitrosothiols